Peter Casasanto
Corporate Officer/Principal at SOPHIA GENETICS SA
Profile
Peter Casasanto is currently the Chief BioPharma Officer at SOPHiA GENETICS SA since 2022.
Previously, he worked as the Vice President-New Commercialization Initiatives at CellCarta Biosciences, Inc. Mr. Casasanto has a graduate degree from Thomas Jefferson University, an undergraduate degree from the University of Maryland, and an MBA from Lebow College of Business.
Peter Casasanto active positions
| Companies | Position | Start |
|---|---|---|
| SOPHIA GENETICS SA | Corporate Officer/Principal | 2022-01-09 |
Former positions of Peter Casasanto
| Companies | Position | End |
|---|---|---|
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Corporate Officer/Principal | - |
Training of Peter Casasanto
| Lebow College of Business | Masters Business Admin |
| Thomas Jefferson University | Graduate Degree |
| University of Maryland | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SOPHIA GENETICS SA | Technology Services |
| Private companies | 1 |
|---|---|
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Commercial Services |
- Stock Market
- Insiders
- Peter Casasanto
